The cannabis market has been one of the most exciting industries to watch over the course of the past few years, but recent trading has shown how a new market can react to speculative trading and legislative issues. The marijuana market as a whole has continued to grow with a massive amount of propensity toward the future which all in all has helped to bring in a new series of institutional investors into the space. All of this, however, has helped to highlight some of the issues surrounding infant markets and where the industry can grow into the future. Many companies throughout the space have been able to benefit from this growth and have since seen their innovation pay off. The hopes are high that these companies can continue to work toward growth as the coming months and years fly by.

One of the companies that has been working to push the cannabis industry forward has been Insys Therapeutics (NASDAQ:INSY). The company is not considered to be one of the pure-play cannabis stocks because they mostly work in the pharmaceutical side of the industry. The company however has various products that have already been permitted to be sold on the open market such as Sybsys, a sublingual spray for use in treating cancer patients. Insys has been one of the primary players in the pharmaceutical side of the market for some time now and continues to present investors with a large amount of opportunity.

On the other side of the market comes an alternative way to invest in the space appropriate titled the Alternative Harvest ETF (OTC:MJ). The ETF has helped to given investors a large amount of exposure to a market that can be quite broad at many points. Many of the companies within the ETF have managed to remain some of the most successful businesses in the whole of the cannabis market and remain at the top of the industry. One of the most exciting parts about this ETF comes from the fact that it can give U.S. investors a solid amount of exposure to the wide variety of Canadian marijuana businesses that they otherwise would not be able to invest in. This has made MJ one of the most popular ETFs to look out for in the coming future.

The company, Cronos Group (NASDAQ:CRON) has been at the top of the market for some time now as one of the biggest marijuana stocks in the space. The company operates by working with and investing in various companies in the cannabis industry which continues to given them an optimal amount of exposure to various sectors of the industry. The company has also been working as a sort of incubator for the cannabis space, helping smaller companies get the help they need to contribute greatly to the growing and innovating cannabis space. Cronos Group remains one of the main stocks to watch as we continue to move toward the future.

The hopes are high that the cannabis industry can continue its reign toward the future as the coming legislative measures go into effect around the world. Only time will tell how the various companies in the space can continue to contribute to the growing market on marijuana.

which marijuana stocks to buy


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

These Two Marijuana Stocks Are Competing For A Spot In Your Portfolio 

MSO marijuana stocks are nothing new to the cannabis industry. Despite the…